Beckman Coulter Inc.
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Beckman Coulter Inc.
The FDA has granted an emergency use authorization for a COVID-19 IgM antibody blood test that runs on Abbott’s Architect and Alinity platforms.
The company expects testing for IgM antibodies will be useful in areas where PCR testing is not keeping up with demand.
Medtech industry group AdvaMed has developed a registry to share data on how many COVID-19 diagnostic tests are available and where they are, with a goal of foreseeing and nipping in the bud potential test shortages. Thirteen diagnostic manufacturers – including Abbott, Roche, Siemens and Thermo Fisher Scientific – have partnered with AdvaMed on the initiative.
The Personal Care Products Council’s top execs identified key legislative, regulatory and public affairs challenges facing industry in 2019 during a Feb. 26 panel discussion at the group’s annual meeting in Palm Beach, Fla.
- Research, Analytical Equipment & Supplies
In Vitro Diagnostics
- Chemistry, Immunoassay
- Hematology, Coagulation
- Molecular Diagnostics & Genetic Testing